Clinical Trial Update: A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma [Phase 4]

View source ↗

Summary

A Phase 4 real-world multicenter study evaluating linperlisib for indolent B-cell lymphoma is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent B-cell Lymphoma

Drugs mentioned

• Linperlisib (linperlisib)

Snippet

Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd. | Conditions: Indolent B-cell Lymphoma | Phase 4 | Status: NOT_YET_RECRUITING